These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2166680)

  • 1. Tissue inhibitor of metalloproteinases from human bone marrow stromal cell line KM 102 has erythroid-potentiating activity, suggesting its possibly bifunctional role in the hematopoietic microenvironment.
    Hayakawa T; Yamashita K; Kishi J; Harigaya K
    FEBS Lett; 1990 Jul; 268(1):125-8. PubMed ID: 2166680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity.
    Murate T; Yamashita K; Ohashi H; Kagami Y; Tsushita K; Kinoshita T; Hotta T; Saito H; Yoshida S; Mori KJ
    Exp Hematol; 1993 Jan; 21(1):169-76. PubMed ID: 8417953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases-1.
    Chesler L; Golde DW; Bersch N; Johnson MD
    Blood; 1995 Dec; 86(12):4506-15. PubMed ID: 8541540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythroid-potentiating activity: characterization and target cells.
    Gauwerky CE; Lusis AJ; Golde DW
    Exp Hematol; 1980; 8 Suppl 8():117-27. PubMed ID: 6984393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue inhibitor of metalloproteinase-2 (TIMP-2) has erythroid-potentiating activity.
    Stetler-Stevenson WG; Bersch N; Golde DW
    FEBS Lett; 1992 Jan; 296(2):231-4. PubMed ID: 1370805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of human T-lymphocyte-derived erythroid-potentiating activity.
    Westbrook CA; Gasson JC; Gerber SE; Selsted ME; Golde DW
    J Biol Chem; 1984 Aug; 259(16):9992-6. PubMed ID: 6332112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine interleukin 9 stimulates the proliferation of mouse erythroid progenitor cells and favors the erythroid differentiation of multipotent FDCP-mix cells.
    Bourette RP; Royet J; Mouchiroud G; Schmitt E; Blanchet JP
    Exp Hematol; 1992 Aug; 20(7):868-73. PubMed ID: 1628705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spleen stromal cell lines selectively support erythroid colony formation.
    Yanai N; Matsuya Y; Obinata M
    Blood; 1989 Nov; 74(7):2391-7. PubMed ID: 2804371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microenvironment created by stromal cells is essential for a rapid expansion of erythroid cells in mouse fetal liver.
    Ohneda O; Yanai N; Obinata M
    Development; 1990 Oct; 110(2):379-84. PubMed ID: 2133543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor with erythroid burst-promoting activity in human urine unlike other hematopoietic growth factors.
    Tsuda E; Kawanishi G; Ueda M; Sato T; Suda T; Miura Y; Sasaki R
    Int J Hematol; 1991 Oct; 54(5):363-9. PubMed ID: 1756247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human interleukin (IL)-9 specifically stimulates proliferation of CD34+++DR+CD33- erythroid progenitors in normal human bone marrow in the absence of serum.
    Lu L; Leemhuis T; Srour EF; Yang YC
    Exp Hematol; 1992 May; 20(4):418-24. PubMed ID: 1373687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human CD34(+) and CD34(+)CD38(-) hematopoietic progenitors in sickle cell disease differ phenotypically and functionally from normal and suggest distinct subpopulations that generate F cells.
    Luck L; Zeng L; Hiti AL; Weinberg KI; Malik P
    Exp Hematol; 2004 May; 32(5):483-93. PubMed ID: 15145217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence in vitro of IL-3/Epo fusion proteins compared with the combination of IL-3 plus Epo in enhancing the proliferation of single isolated erythroid and multipotential progenitor cells from human umbilical cord blood and adult bone marrow.
    Lu L; Xiao M; Li ZH; Jolliffe LK; Jones S; Broxmeyer HE; Weich N
    Exp Hematol; 1995 Sep; 23(10):1130-4. PubMed ID: 7656932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-lymphocyte-derived burst-promoting activity is a pleiotropic erythroid colony-stimulating factor, E-CSF.
    Feldman L; Frazier JG; Sytkowski AJ
    Exp Hematol; 1992 Nov; 20(10):1223-8. PubMed ID: 1426102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of functional human CSF-1 receptors on mouse bone marrow erythroid progenitor cells.
    Mouchiroud G; Bourette R; Blanchet JP
    C R Acad Sci III; 1993 Nov; 316(11):1290-6. PubMed ID: 8087610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity.
    Docherty AJ; Lyons A; Smith BJ; Wright EM; Stephens PE; Harris TJ; Murphy G; Reynolds JJ
    Nature; 1985 Nov 7-13; 318(6041):66-9. PubMed ID: 3903517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of purified human erythroid-potentiating activity.
    Gasson JC; Bersch N; Golde DW
    Prog Clin Biol Res; 1985; 184():95-104. PubMed ID: 3931094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a new metalloproteinase inhibitor that forms tight-binding complexes with collagenase.
    Cawston TE; Curry VA; Clark IM; Hazleman BL
    Biochem J; 1990 Jul; 269(1):183-7. PubMed ID: 2165393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells.
    Bilgeri R; Petzer AL; Zilian U; Geisen FH; Schirmer M; Haun M; Konwalinka G
    Exp Hematol; 1993 Mar; 21(3):432-7. PubMed ID: 8095026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification of an inhibitor of erythroid progenitor cell cycling and antagonist to interleukin 3 from mouse marrow cell supernatants and its identification as cytosolic superoxide dismutase.
    Pluthero FG; Shreeve M; Eskinazi D; van der Gaag H; Huang KS; Hulmes JD; Blum M; Axelrad AA
    J Cell Biol; 1990 Sep; 111(3):1217-23. PubMed ID: 2391363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.